Vera Therapeutics, Inc. Class A Common Stock Share Price
NASDAQ: VERAHealthcare
Live Vera Therapeutics, Inc. Class A Common Stock Share Price Chart
O H L
Vera Therapeutics, Inc. Class A Common Stock Performance Overview
Days Range
▼
$29.52Low
$30.47High
Markets Today
| Previous Close | $29.73 |
|---|---|
| Open | $29.52 |
| Volume | 996,316 |
| Day's Range | $29.52 - $30.47 |
| 52W Range | $23.05 - $56.05 |
| Market Cap | $2.14 B |
Historical Performance
| 1M Returns | -11.07 |
|---|---|
| 3M Returns | -28.86 |
| 6M Returns | -33.66 |
| 1Y Returns | -0.70 |
| 5Y Returns | +85.71 |
| 10Y Returns | NA |
Vera Therapeutics, Inc. Class A Common Stock Fundamentals
| Market Cap | $2.14 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.51 |
| EPS TTM | $-5.86 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 5.25 |
| EBITDA | $-315.00 M |
| Profit Margin | N/A |
| Market Cap | $2.14 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.51 |
| EPS TTM | $-5.86 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 5.25 |
| EBITDA | $-315.00 M |
| Profit Margin | N/A |
Vera Therapeutics, Inc. Class A Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$57.19 M | -$80.14 M | -$83.93 M | -$94.21 M | -$125.13 M | -$112.49 M |
| EBITDA | -$57.11 M | -$80.02 M | -$83.80 M | -$94.07 M | -$124.99 M | -$112.36 M |
| Interest Expense | -$1.79 M | -$1.87 M | -$1.96 M | -$1.90 M | -$1.82 M | -$1.85 M |
| Depreciation | $85.00 K | $119.00 K | $129.00 K | $135.00 K | $140.00 K | $132.00 K |
| Income Before Tax | -$51.43 M | -$76.66 M | -$80.29 M | -$91.10 M | -$121.97 M | -$109.72 M |
| Income Tax Expense | $0 | $0 | $0 | $1.00 K | $0 | $0 |
| Net Income + | -$51.43 M | -$76.66 M | -$80.29 M | -$91.10 M | -$121.97 M | -$109.72 M |
| Net Profit Margin | - | - | - | - | - | - |
Vera Therapeutics, Inc. Class A Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $64.00 K | $64.00 K | $64.00 K | $71.00 K | $72.00 K | $72.00 K |
| Reserve & Surplus | -$512.29 M | -$588.95 M | -$668.89 M | -$760.08 M | -$882.05 M | -$991.77 M |
| Non-Current Liabilities | $53.27 M | $76.70 M | $76.74 M | $76.76 M | $76.89 M | $76.91 M |
| Current Liabilities | $21.89 M | $33.55 M | $41.88 M | $53.45 M | $45.15 M | $48.32 M |
| Total Liabilities | $75.17 M | $110.25 M | $118.62 M | $130.21 M | $122.04 M | $125.23 M |
| Fixed Assets | $1.06 M | $1.15 M | $1.16 M | $0 | $0 | $0 |
| Current Assets | $606.08 M | $571.35 M | $511.31 M | $728.88 M | $615.80 M | $527.49 M |
| Total Assets | $610.17 M | $578.53 M | $517.50 M | $734.73 M | $621.74 M | $532.98 M |
Vera Therapeutics, Inc. Class A Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$51.69 M | -$76.53 M | -$80.29 M | -$91.10 M | -$121.03 M | -$109.47 M |
| Operating Cash Flow | -$54.41 M | -$54.80 M | -$61.91 M | -$69.99 M | -$106.50 M | -$100.25 M |
| Investing Cash Flow | $15.32 M | $28.54 M | $69.76 M | $80.66 M | -$137.82 M | $32.86 M |
| Financing Cash Flow | $1.53 M | $20.29 M | $797.00 K | $286.28 M | $3.94 M | $1.92 M |
| Change in Cash | -$37.56 M | -$5.97 M | $8.65 M | $296.95 M | -$240.37 M | -$65.47 M |
Vera Therapeutics, Inc. Class A Common Stock Return Calculator
The Vera Therapeutics, Inc. Class A Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$18,571
Invested Amount$10,000
Est. Returns$8,571
About Vera Therapeutics, Inc. Class A Common Stock
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Popular Stocks
FAQs
What is the share price of Vera Therapeutics, Inc. Class A Common Stock today?
Vera Therapeutics, Inc. Class A Common Stock (VERA) share price as of October 10, 2026 is $29.88. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Vera Therapeutics, Inc. Class A Common Stock?
Yes, Indian Investors can invest in the Vera Therapeutics, Inc. Class A Common Stock (VERA) Share by opening an international trading account with Angel One.
How can I purchase Vera Therapeutics, Inc. Class A Common Stock shares in India?
Purchasing Vera Therapeutics, Inc. Class A Common Stock (VERA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Vera Therapeutics, Inc. Class A Common Stock (VERA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Vera Therapeutics, Inc. Class A Common Stock?
Yes, you can purchase fractional shares of Vera Therapeutics, Inc. Class A Common Stock (VERA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Vera Therapeutics, Inc. Class A Common Stock?
The market capitalization of Vera Therapeutics, Inc. Class A Common Stock on October 10, 2026, is $2.14 B.
In which sector Vera Therapeutics, Inc. Class A Common Stock belongs?
Vera Therapeutics, Inc. Class A Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Vera Therapeutics, Inc. Class A Common Stock stocks?
In order to invest in Vera Therapeutics, Inc. Class A Common Stock (VERA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
